NIH begins study of remdesivir with anti-inflammatory drug to treat COVID-19

Reuters

08 May 2020 0 shares 1 views

NIH begins study of remdesivir with anti-inflammatory drug to treat COVID-19

Reuters

Published 08 May 2020

The National Institutes of Health said on Friday it has started a clinical study to test a combination of Gilead Sciences Inc's antiviral drug remdesivir and anti-inflammatory drug baricitinib in COVID-19 patients.

Full Article

Roche to study remdesivir/Actemra cocktail against severe COVID-19 pneumonia

Swiss drugmaker Roche said on Thursday it would study its anti-inflammation drug Actemra mixed with Gilead Sciences Inc's..

Reuters 28 May 2020

NIH begins study of remdesivir with anti-inflammatory drug to treat COVID-19

NIH begins study of remdesivir with anti-inflammatory drug to treat COVID-19

You might like

Related news coverage

Roche to study remdesivir/Actemra cocktail against severe COVID-19 pneumonia

Advertisement